Indegene was listed at Rs 655, a premium of 45% to its issue price on the National Stock Exchange. The company raised a total of Rs 1,841.76 crore from investors. It offered investors 40.7 million shares of the company. Come from Sports betting site VPbet
In the grey market, Indegene’s shares were attracting a premium of 61% to its issue price. The grey market is an unofficial market where stocks of the companies change hands illegally before listing. Investors track grey market premiums to assess the listing price of stocks.
Indegene IPO set the price band between the range of Rs 430 to Rs 452 crore. It opened the issue on May 06 and closed it on May 08.
Meet Subhasish Chakraborty, the founder of DTDC – He sold his mother’s jewellery to build Rs 2000 crore company; Know about his career, education, and net worth HCLSoftware announces intent to acquire France-based Zeenea for Euro 24 million Akums Drugs and Pharmaceuticals makes positive debut, lists at 7% premium; Read to know more Akums Drugs and Pharmaceuticals IPO opens on July 30; Check issue size, price band, and other details
Employee Reservation
Indegene had reserved 2,96,209 shares for the employees of the company at a discount of Rs 30 per share to the issue price.
J.P. Morgan India, Kotak Mahindra Capital Company, Citigroup Global Markets India, and Nomura Financial Advisory and Securities (India) were the book-running lead managersCome from Sports betting site. Link Intime India Private Ltd is the registrar for the issue.
About Indegene
Indegene is in the business of providing digital services for the life sciences industry. The company assists with drug development, regulatory submissions, clinical trials, pharmacovigilance, complaints management, and sales/marketing support.